Eisai Inc. (LENVIMA)
(https://lenvima.com) 📸 Data Snapshot: May 30, 2026Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Trust theatre is nearly non-existent, with the notable exception of a technical anomaly on the ‘thank-you’ page (slot 2) where a review_count of 1 and a trust_theatre_flag are present despite no review text being visible. The site employs high-integrity forensic markers, such as the ‘Actor portrayal’ disclaimer for its imagery, which proactively reduces bullshit by admitting the photography is illustrative rather than testimonial.
The proof density is high, particularly for a patient-facing site. Verifiable evidence includes the specific n-count for clinical trials (392) and the exact FDA-approved indications for use. The only lack of proof is the absence of direct outbound links to peer-reviewed publications (PMIDs) or ClinicalTrials.gov identifiers within the provided text snippets, though the data referenced is specific enough for independent verification.
Trust & Proof is read by weighing trust language against real verification. Below is the page-by-page tally of review mentions and external proof links, then the schema markup that may (or may not) declare verifiable ratings and identity proof.
🛡️ Trust Signals — reviews, proof links, trust-theatre check
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /thank-you-for-visiting/ | 0 | 0 |
| /thank-you/ | 1 | 0 |
| /differentiated-thyroid-cancer/ | 0 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: declared ratings, reviews & identity proof
Homepage schema
[
{
"@context": "https://schema.org",
"@type": "Drug",
"name": "Lenvima",
"nonProprietaryName": "lenvatinib",
"administrationRoute": "oral",
"dosageForm": "capsules",
"drugUnit": "10mg and 4mg capsule",
"manufacturer": "Eisai"
},
{
"@context": "https://schema.org",
"@type": "MedicalWebPage",
"url": "https://www.lenvima.com",
"audience": "patients"
}
]
/differentiated-thyroid-cancer/
[
{
"@context": "https://schema.org",
"@type": "Drug",
"name": "Lenvima",
"nonProprietaryName": "lenvatinib",
"administrationRoute": "oral",
"dosageForm": "capsules",
"drugUnit": "10mg and 4mg capsule",
"manufacturer": "Eisai"
},
{
"@context": "https://schema.org",
"@type": "MedicalWebPage",
"url": "https://www.lenvima.com/differentiated-thyroid-cancer",
"audience": "patients",
"name": "Differentiated Thyroid Cancer",
"about": [
"LENVIMA is used by itself to treat differentiated thyroid cancer (DTC), a type of thyroid cancer that can no longer be treated with radioactive iodine and is progressing",
"For the treatment of adult patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer"
]
}
]
This page presents a snapshot of public data from Eisai Inc. (LENVIMA), captured on May 30, 2026, to show how machine logic reads Trust & Proof signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Eisai Inc. (LENVIMA): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://lenvima.com to view the most current version of its content and see directly what this company is about and what it offers.